INTRODUCTION
============

Hereditary retinal disease is one of the important causes of blindness, which leads to an irreversible retinal damage affecting the quality of life and daily activities. Bestrophinopathy is one of the most common inherited macular degenerations, and it is caused by mutations in the *BEST1* gene. *BEST1* is located in chromosome 11q13,[@B1][@B2] and encodes a 585 amino acid protein known as bestrophin that localizes to the basolateral membrane of the retinal pigment epithelium (RPE).[@B3] When mutated, lipofuscin accumulates beneath the RPE, with degeneration of the RPE and the overlying photoreceptors.[@B4] The broad spectrum of clinical presentations in bestrophinopathy ranges from well-defined clinical abnormalities restricted to the macula in Best disease \[BD, also known as vitelliform macular dystrophy; Online Mendelian Inheritance in Man (OMIM) 153700\] and autosomal recessive bestrophinopathy (ARB; OMIM 611809) to the widespread symptoms affecting peripheral retina in a rare condition of autosomal dominant vitreoretinochoroidopathy (ADVIRC; OMIM 193220).[@B5][@B6]

BD was first described by Friedrich Best in 1905,[@B7] and is most common among bestrophinopathies. BD occurs in about 1 in every 10000 individuals, and is inherited by autosomal dominant fashion.[@B6] The age at onset of BD is variable, with a mean age onset in the fourth decade.[@B8] The macular lesion that is most characteristic of the disease is single egg-yolk-like vitelliform lesion on the central fovea, which is usually followed by vitelliruptive stage, pseudohypopyon stage, and atrophic stage.[@B6] A significantly decreased light rise on electrooculography (EOG) is a characteristic finding of BD.[@B9] Although an abnormal EOG is crucial in the diagnosis of BD in patients with vitelliform lesions, mutation analysis is necessary to confirm a clinical diagnosis of BD since 20% of patients with *BEST1* mutation could have a normal EOG.[@B10]

*BEST1* mutation has long been believed to segregate only in an autosomal dominant manner. Then, autosomal recessive disease with *BEST1* mutation was first defined as a distinct category of bestrophinopathy by Burgess, et al.[@B11] in 2008, which is now widely known as ARB.[@B6] Nearly 40 biallelic mutations in *BEST1* have been reported in ARB patients to date.[@B12][@B13][@B14][@B15] Retinopathy includes an irregularity of the RPE throughout the posterior fundus with punctate flecks, which is easily seen on autofluorescence imaging. Retinal edema and subretinal fluid are common findings on OCT imaging. ARB shows markedly abnormal EOG and pattern electroretinography (ERG).[@B11]

Human induced pluripotent stem cells (iPSC) are relatively non-invasive and renewable, and iPSC-derived models can recapitulate cellular and molecular processes without genetic manipulation.[@B16] The retina and the brain are promising candidates for iPSC modeling as it is difficult to perform biopsy in these tissues, and there are established preexisting protocols to isolate their progenitors from iPSC.[@B17][@B18][@B19] The RPE can be readily differentiated and re-seeded widely, which is a promising candidate for iPSC modeling. In this study, we sought to model BD and ARB using iPSC technology, which would be useful in studying the pathophysiology and therapeutic targets of *BEST1*-associated retinopathy.

MATERIALS AND METHODS
=====================

Differentiation of human iPSC lines
-----------------------------------

### Generation of iPSC lines

This study was approved by the Institutional Review Board of Severance Hospital, Yonsei University College of Medicine (3-2017-0167). Twenty milliliters of peripheral blood were obtained from one ARB patient (L40P and A195V mutations in *BEST1* gene), one autosomal dominant BD patient (G96A mutation in BEST1 gene), and two normal controls. Human iPSC lines were generated using previously established methods.[@B17][@B18] Mononuclear cells (MNC) were isolated from the blood samples and were expanded in MNC media for 7--10 days.

MNC were transfected with episomal vectors (OCT4, SOX2, c-MYC, KLF4, LIN28) (Thermo Fisher Scientific, Waltham, MA, USA) and cultured on extracellular matrices (BD, Franklin Lakes, NJ, USA). Culture on iPSC medium (STEMCELL Technologies, Vancouver, Canada) were performed for 1--2 weeks till colonization of iPSC. iPSC colonies were isolated and expanded on iPSC medium (STEMCELL Technologies). Differentiation was initiated after 10--20 passages of expansion to remove an epigenetic memory.

### Differentiation of iPSC into functional RPE cell

Embryoid body (EB) was formed for 1 week on EB media (Thermo Fisher Scientific) and free-floating culture. EB was then switched to a chemically defined neural induction media (Thermo Fisher Scientific) and laminin-coated plate (Thermo Fisher Scientific) for 10 days for neural differentiation. For retinal differentiation, iPSC-derived neuroepithelial rosettes were switched to a chemically defined retinal differentiation medium (Thermo Fisher Scientific).

RT-PCR
------

Total RNA was isolated from cell cultures from various stages of differentiation and treated with DNase I (Thermo Fisher Scientific). cDNA was synthesized using the SuperScript III RT-PCR kit (Thermo Fisher Scientific). Samples were denatured at 95℃ for 5 minutes followed by 30 cycles of PCR amplification (95℃ for 15 seconds, 60℃ for 30 seconds, 72℃ for 1 minute) and a final extension at 72℃ for 10 minutes. PCR products were run on 2% agarose gel.

Immunocytochemistry
-------------------

Cells were washed in ice-cold phosphate-buffered saline (PBS) and fixed in 2--4% paraformaldehyde at 4℃ for 30 minutes. Fixed cells were washed twice in PBS and placed in blocking solution (10% normal donkey or goat serum and 0.01--0.05% Triton-X100 in PBS) for 1 hour at room temperature. Cells were then incubated overnight at 4℃ with mouse anti-*BEST1* monoclonal antibody (E6-6) (Thermo Fisher Scientific) and rabbit anti-ZO-1 polyclonal antibody (Thermo Fisher Scientific). The following day, cells were washed three to five times in PBS with 0.01% Triton-X100 and incubated with Alexa Fluor 488-conjugated goat anti-rabbit antibody (Thermo Fisher Scientific) and Alexa Fluor 568-conjugated donkey anti-rabbit antibody (Thermo Fisher Scientific). After secondary antibody incubation, cells were stained with DAPI (Thermo Fisher Scientific), washed three times in PBS with 0.2% Triton-X100, and imaged on a confocal microscope (Zeiss, Jena, Germany).

Transepithelial resistance (TER) measurement
--------------------------------------------

TER of RPE monolayers cultured on permeable transwell filters (Merck KGaA, Darmstadt, Germany) was measured using an epithelial voltohmmeter (Merck KGaA) according to manufacturer\'s instructions. Electrodes were sterilized with 70% ethanol and rinsed in Hank\'s balanced salt solution prior to placement in the transwell inserts. Net TER was calculated by subtracting the background measurement obtained from transwell filters and multiplying the difference by the area of the transwell filter (Ω^\*^cm^2^).

Measurement of fluid flux
-------------------------

The quantification of active fluid transport from apical to basal side in the RPE was measured using a previously described method.[@B20] A fixed amount of medium (Thermo Fisher Scientific), 150 µL in the apical and 400 µL in the basal chambers of transwell, was loaded. The amount of fluid remaining in the apical chamber was measured 20 hours later, and the rate of fluid transport was calculated (µL/hr/cm^2^).

RNA sequencing and data analysis
--------------------------------

RNA sequencing was performed on ARB iPSC-RPE, BD iPSC-RPE, and normal iPSC-RPE (n=2 for each) using the Macrogen (Seoul, Korea). Total RNA quality was assessed with Agilent bioanalyzer system (Agilent, Santa Clara, CA, USA). Extracted RNA samples were processed with TruSeq Stranded Total RNA Prep Kit (Illumina, San Diego, CA, USA) and sequenced on NovaSeq 6000 system (Illumina). A median 1.2×10^8^ single-end reads (range, 1.1×10^8^ to 1.3×10^8^) with 101 base pairs were generated. Reads were trimmed based on sequencing quality using Trimmomatic (RWTH Aachen University, Aachen, Germany).[@B21] Trimmed reads were aligned on a human reference sequence (hg19) using HISAT2 (Johns Hopkins University, Baltimore, MD, USA).[@B22] Using Gene Set Enrichment Analysis, an enrichment of a specific gene set was tested, and core enrichment genes were determined.[@B23]

Statistical analysis
--------------------

All statistical analyses were performed using SPSS version 23.0 (IBM Corp., Armonk, NY, USA). Shapiro-Wilk test was used to assess distribution patterns of data. TER measurement and the rate of fluid flow obtained from ARB iPSC-RPE were compared with those of control and BD iPSC-RPE using Mann-Whitney test. A *p*-value \<0.05 was considered statistically significant.

RESULTS
=======

Clinical findings
-----------------

Demographics and characteristics of patient with Best vitelliform macular dystrophy and patient with ARB are summarized in [Table 1](#T1){ref-type="table"}. Patient 1 was a 41-year-old woman with decreased visual acuity in the right eye. Her best-corrected visual acuity was 20/40 in the right eye and 20/20 in the left eye. The patient was hyperopic with spherical equivalent +1.75 diopter (OD) and +1.00 diopter (OS). The fundus showed RPE atrophy and pigment disruption in the right eye and a dome-shaped accumulation of yellowish material in the central macula of the left eye ([Fig. 1A and B](#F1){ref-type="fig"}). Hyperreflective vitelliform materials with subretinal fluid were found in the subretinal space on OCT images ([Fig. 1C and D](#F1){ref-type="fig"}). EOG showed decreased response with Arden ratio 1.1 in both eyes.

Patient 2 was a 57-year-old woman who reported significant visual loss in both eyes at the age of 20 years. She presented with a further decrease of the visual acuity in her left eye for 2 months. Her visual acuity was 20/400 in the right eye and 20/800 in the left eye. The patient was hyperopic with spherical equivalent +3.00 diopter (OD) and +3.25 diopter (OS). The fundus showed bilateral RPE irregularities in the posterior pole with scattered yellowish flecks ([Fig. 2A and B](#F2){ref-type="fig"}), which were more prominent on autofluorescence images. A neurosensory retinal detachment with subretinal fluid was observed in the left eye on an OCT image, which appeared similar to that of the fellow eye ([Fig. 2C](#F2){ref-type="fig"}). Electrophysiology showed normal response for the full-field ERG, but a light rise on EOG was absent (Arden ratio 1.0) in both eyes.

Generation of iPSC lines
------------------------

MNC were isolated from peripheral blood, and iPSC lines were generated using previously established methods.[@B17][@B18] Immunocytochemistry and RT-PCR in iPSC lines were performed to confirm the pluripotent markers. Immunocytochemistry analysis using confocal microscopy demonstrated that all iPSC lines expressed the pluripotent markers including OCT4, SOX2, TRA-1-60, and SSEA4 ([Fig. 3](#F3){ref-type="fig"}). RT-PCR revealed pluripotency markers including c-MYC, OCT4, SOX2, NANOG, and KLF4 ([Fig. 4](#F4){ref-type="fig"}), and teratoma studies confirmed that 7-day embryoid bodies derived from iPSC showed markers for all three lineages ([Fig. 5](#F5){ref-type="fig"}).

Differentiation of iPSC into RPE cell
-------------------------------------

Light microscopy and RT-PCR were performed to confirm the differentiation of iPSC into the RPE cell. RPE differentiation was performed in retinal differentiation media until approximately Day 40--90, at which characteristic polygonality and pigmentation of the RPE could be confirmed on light microscopy ([Fig. 6A](#F6){ref-type="fig"}). RT-PCR revealed the expressions of a characteristic RPE gene *BEST1* and a tight junction gene OCCLUDIN ([Fig. 6B](#F6){ref-type="fig"}).

Cytological and functional analysis of ARB iPSC-RPE
---------------------------------------------------

Morphological characteristics of the RPE were evaluated using confocal microscopy and immunocytochemistry. The rate of fluid flow across iPSC-RPE monolayer on transwell insert was measured to compare apical to basal fluid transports by the RPE. Immunocytochemistry revealed uniform tight junction protein ZO-1 in both ARB and control iPSC-RPE ([Fig. 7](#F7){ref-type="fig"}). There was no significant difference in TER measurements between ARB patient, autosomal dominant BD patient, and normal control ([Table 2](#T2){ref-type="table"}). TER measurements obtained from ARB iPSC-RPE (290.00±10.24 Ω) were similar to those of BD iPSC-RPE (312.67±23.84 Ω, *p*=0.936) and control iPSC-RPE (305.83±13.33 Ω, *p*=0.335) ([Fig. 8A](#F8){ref-type="fig"}). The rate of fluid flow was the lowest in ARB iPSC-RPE (0.12±0.01), and was significantly lower than those of control iPSC-RPE (0.35±0.02, *p*\<0.001) and BD iPSC-RPE (0.29±0.02, *p*\<0.001) ([Fig. 8B](#F8){ref-type="fig"}).

Gene expression profiles of ARB iPSC-RPE
----------------------------------------

RNA-sequencing was performed to identify the differences in gene expression profiles between ARB iPSC-RPE, BD iPSC-RPE, and control iPSC-RPE. Gene Set Enrichment Analysis showed that ARB iPSC-RPE exhibited significant enrichment of epithelial-mesenchymal transition (EMT) gene set compared with control iPSC-RPE ([Fig. 9A](#F9){ref-type="fig"}). Genes encoding TNF-α signaling via NF-κB were also significantly enriched in ARB iPSC-RPE compared with control iPSC-RPE ([Fig. 9B](#F9){ref-type="fig"}). ARB iPSC-RPE showed similar results compared with BD iPSC-RPE ([Fig. 9C and D](#F9){ref-type="fig"}).

DISCUSSION
==========

In this study, a human iPSC model of ARB was evaluated to understand its pathophysiology, which revealed a functional deficiency rather than anatomical defects. Morphological characteristics, gene expression, and epithelial integrity of ARB iPSC were comparable to those of normal control. Fluid transport from apical to basal was more reduced in ARB iPSC-RPE than in autosomal dominant BD iPSC-RPE.

RPE-based disorders appear to be ideal for human iPSC modeling, given the ease and extent to which this cell type can be generated, manipulated, and tested. The maturation state of iPSC-RPE can be also monitored in live cultures using morphological features and measurement of TER.[@B24] Singh, et al.[@B16] developed a iPSC-RPE model of Best vitelliform macular dystrophy utilizing these characteristics of human RPE. They demonstrated that RPE from mutant iPSC displayed disrupted fluid flux and increased accrual of autofluorescent material after long-term photoreceptor outer segment feeding. Therefore, human iPSC-derived RPE is a potentially useful tool for disease modeling and therapeutics in human retinal degenerative diseases.

Defect in transcellular fluid in iPSC-RPE was more prominent in ARB patient than in autosomal dominant BD patient, which could explain the common macular edema and subretinal fluid in ARB patient. The macular pathology in BD patients usually seems to be stable until the late stage of the disease course, and most patients retain moderate visual acuity until later in life.[@B25][@B26] Therefore, the result may also suggest that BD is caused by the cumulative effects of one or more subtle alterations in RPE physiology. Other cytological examinations, including morphological characteristics, gene expression, and epithelial integrity, revealed similar results between ARB iPSC-RPE and normal control. Considering the more prominent defect in transcellular fluid in ARB iPSC-RPE than in autosomal dominant BD iPSC-RPE, these findings may suggest that ARB is caused by *BEST1* dysfunction.

EMT is a biologic process resulting in the conversion of epithelial cells to myofibroblasts.[@B27][@B28] It is characterized by the loss of epithelial characteristics, which includes apical-basolateral polarity and cell-cell adhesions.[@B29] Increased expressions of transforming growth factor-β, α-smooth muscle actin, extracellular matrix proteins collagen type 1, and matrix metalloproteinases induce this process.[@B27][@B29][@B30][@B31] EMT of the RPE is known to be related to the pathogenesis of subretinal fibrosis in various retinal diseases, including age-related macular degeneration.[@B32][@B33][@B34] NF-κB activation by TNF-α is well-known to play a crucial role in EMT.[@B35][@B36][@B37][@B38] Recently, an association between EMT genes and genes involved in NF-κB activation has been reported.[@B37][@B39][@B40] Gene expression profiles of ARB iPSC-RPE exhibited significant enrichment of EMT gene set compared to control iPSC-RPE or BD iPSC-RPE. Genes encoding TNF-α signaling via NF-κB was also enriched in ARB iPSC-RPE compared to control iPSC-RPE or BD iPSC-RPE. These results indicate that inhibiting EMT and NF-κB activation in the RPE could be a potential therapeutic target for ARB.

The lack of peripheral retinal findings in BD and ARB is possibly related to the capacity for RPE cells to withstand the presence of dysfunctional *BEST1*. This difference in phenotype between central and peripheral retina in BD and ARB could be explained by regional differences in the RPE or superimposed environmental stress upon the macular RPE.[@B16] Further studies are necessary to evaluate whether iPSC-RPE cells are more similar to macula or peripheral retina. Studies on ADVIRC iPSC-RPE would be also useful in finding the difference between central and peripheral lesions of bestrophinopathy.

In conclusion, this study established an in vitro model of ARB, which showed a functional deficiency rather than anatomical defects. Fluid transport from apical to basal was significantly reduced in ARB iPSC-RPE compared to that of autosomal dominant BD iPSC-RPE. ARB may be caused by RPE dysfunction following *BEST1* mutation.
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![Clinical findings of Patient 1. A 41-year-old woman presented with decreased visual acuity in the right eye. (A and B) Color fundus photography showed RPE atrophy and pigment disruption in the right eye and a dome-shaped accumulation of yellowish material in the central macula of the left eye. (C and D) Hyperreflective materials with subretinal fluid were found in the subretinal space on optical coherence tomographic images. RPE, retinal pigment epithelium.](ymj-61-816-g001){#F1}

![Clinical findings of Patient 2. A-57-year-old woman presented with decreased visual acuity in her left eye for 2 months. She had reported significant visual loss in both eyes at the age of 20 years. (A and B) Color fundus photography showed bilateral RPE irregularities in the posterior pole with scattered yellowish flecks. (C) A neurosensory retinal detachment with subretinal fluid was observed in the left eye on an optical coherence tomography image, which appeared similar to that of the fellow eye. RPE, retinal pigment epithelium.](ymj-61-816-g002){#F2}

![Immunocytochemistry in iPSC lines. Immunocytochemistry analysis demonstrated the expression of pluripotency markers (OCT4, SOX2, TRA1-60, and SSEA4) in all iPSC lines of normal controls and patients. iPSC, induced pluripotent stem cell; BD, Best disease; ARB, autosomal recessive bestrophinopathy.](ymj-61-816-g003){#F3}

![RT-PCR in iPSC lines. RT-PCR revealed mRNA expression of pluripotency markers (c-MYC, OCT4, SOX2, NANOG, and KLF4) in undifferentiated iPSC lines from normal controls and patients. Human embryonic stem cells (H9) were used as a positive control. iPSC, induced pluripotent stem cell.](ymj-61-816-g004){#F4}

![Teratoma analyses of iPSC lines. Teratoma studies from normal controls and patients demonstrated derivatives from the endodermal, ectodermal, and mesodermal germ lineages. iPSC, induced pluripotent stem cell.](ymj-61-816-g005){#F5}

![Differentiation of induced pluripotent stem cells into functional RPE cells. (A) Characteristic polygonality and pigmentation of the RPE could be confirmed using light microscopy. (B) RT-PCR revealed the expressions of a characteristic RPE gene BEST1 and a tight junction gene OCCLUDIN. GAPDH was as a loading control. BD iPSC-RPE, Best disease induced pluripotent stem cell retinal pigment epithelium; ARB iPSC-RPE, autosomal recessive bestrophinopathy induced pluripotent stem cell retinal pigment epithelium.](ymj-61-816-g006){#F6}

![Immunocytochemistry in iPSC-RPE. Immunocytochemistry for BEST1 and ZO-1 showed uniform morphology and tight junction in Best disease, ARB, and control iPSC-RPE. BD iPSC-RPE, Best disease induced pluripotent stem cell retinal pigment epithelium; ARB iPSC-RPE, autosomal recessive bestrophinopathy induced pluripotent stem cell retinal pigment epithelium.](ymj-61-816-g007){#F7}

![TER measurements and the quantification of fluid movement in BD iPSC-RPE, ARB iPSC-RPE, and control iPSC-RPE. (A) TER were comparable between patients and control iPSC-RPE. (B) The rate of fluid flow was the lowest in ARB iPSC-RPE, and was significantly lower than those of control iPSC-RPE and BD iPSC-RPE. ^\*^*p*\<0.001 compared with control or BD iPSC-RPE. BD iPSC-RPE, Best disease induced pluripotent stem cell retinal pigment epithelium; ARB iPSC-RPE, autosomal recessive bestrophinopathy induced pluripotent stem cell retinal pigment epithelium; TER: transepithelial resistance.](ymj-61-816-g008){#F8}

![GSEA plots showed that epithelial-mesenchymal transition gene set and TNF-α signaling via NF-κB gene set were significantly enriched in ARB iPSC-RPE compared with control iPSC-RPE (A and B) or BD iPSC-RPE (C and D). GSEA, Gene Set Enrichment Analysis; ARB iPSC-RPE, autosomal recessive bestrophinopathy induced pluripotent stem cell retinal pigment epithelium; BD iPSC-RPE, Best disease induced pluripotent stem cell retinal pigment epithelium; FDR, false discovery rate; NES, normalized enrichment score; NOM, nominal.](ymj-61-816-g009){#F9}

###### Demographics and Characteristics of Patients and Normal Controls

![](ymj-61-816-i001)

  Patient     Sex         Age   Diagnosis    ERG   EOG    Inheritance   *BEST1* mutation   Amino acid change
  ----------- ----------- ----- ------------ ----- ------ ------------- ------------------ -------------------
  NL 1        F           46    NL control   NL    NL     NA            NA                 NA
  NL 2        M           44    NL control   NL    NL     NA            NA                 NA
  Patient 1   F           41    BD           NL    Flat   AD            c.287A\>G          Gln96Arg
  Patient 2   F           57    ARB          NL    Flat   AR            c.119T\>C          Leu40Pro
  c.584C\>T   Ala195Val                                                                    

AD, autosomal dominant; AR, autosomal recessive; ARB, autosomal recessive bestrophinopathy; BD, Best disease; EOG, electrooculography; ERG, electroretinography; NA, not applicable; NL, normal; F, female; M, male.

###### TER Measurement and the Rate of Fluid Flow in BD iPSC-RPE and ARB iPSC-RPE

![](ymj-61-816-i002)

                             Control        BD iPSC-RPE    *p* value   ARB iPSC-RPE   *p* value
  -------------------------- -------------- -------------- ----------- -------------- -----------
  TER (Ω^\*^cm^2^)           305.83±13.33   312.67±23.84   0.936       290.00±10.24   0.335
  Fluid flow (µL/hr/cm^2^)   0.35±0.02      0.29±0.02      0.038       0.12±0.01      \<0.001

ARB iPSC-RPE, autosomal recessive bestrophinopathy induced pluripotent stem cell retinal pigment epithelium, BD iPSC-RPE, Best disease induced pluripotent stem cell retinal pigment epithelium, TER, transepithelial resistance
